The automated diagnostic test can analyze up to 120 samples at a time and produce results within an hour. The serological test works by looking for antibodies produced by the body’s immune system after a Zika infection, which can be detected approximately two weeks after the initial infection and up to three months later. The development of serological tests for Zika diagnoses is critical to controlling outbreaks of the virus since 80 percent of those infected with Zika display no symptoms.
“Accurate, rapid Zika diagnostic tests to determine whether someone recently has been infected are critical to ensuring the best health outcomes during the current outbreak,” said Richard Hatchett, MD, acting director for ASPR’s Biomedical Advanced Research and Development Authority. “Identifying Zika cases more quickly helps people take steps to avoid additional transmission that much sooner, which helps protect pregnant women and others at risk of Zika infection.”
More articles on the Zika virus:
Man dies in Puerto Rico from Zika-related paralysis
CDC: Aerial spraying not an option for Miami Beach’s Zika fight
Up to 270 babies may be born with Zika-related microphealy in Puerto Rico
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.